SCHEMBL6153707

SCHEMBL6153707

CN1CCC(Nc2ccc(C(N)=O)cc2Br)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
FLT3 P36888 1/20 0.42
CYP3A4 P08684 1/20 0.42
RPS6KB1 P23443 1/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
JAK3 P52333 1/20 0.41
PRKD1 Q15139 1/20 0.41
PRKD2 Q9BZL6 1/20 0.41
CHEK2 O96017 1/20 0.40
AURKA O14965 1/20 0.40
AURKB Q96GD4 1/20 0.40
HDAC1 Q13547 1/20 0.39
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CHEK1 O14757 1/20 0.38
LRRK2 Q5S007 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153408 0.84 FLT3 (0.48) ALDH1A1KDM4EHSD17B10FLT3RPS6KB1
Hydrochloric Acid SCHEMBL6153648 0.83 FLT3 (0.47) ALDH1A1KDM4EHSD17B10FLT3RPS6KB1
SCHEMBL6154057 0.81 GPR119 (0.54) ALDH1A1CHEK2
SCHEMBL6155256 0.81 TOP2A (0.42) RPS6KB1JAK2JAK1JAK3PRKD1
SCHEMBL6156960 0.80 OPRK1 (0.55) ALDH1A1KDM4ECYP3A4PKMSMN1; SMN2
SCHEMBL6154880 0.77 POLB (0.59) ALDH1A1FLT3JAK2JAK1JAK3
SCHEMBL22605677 0.72 JAK2 (0.50) ALDH1A1KDM4ECYP3A4RPS6KB1JAK2
SCHEMBL31739717 0.72 APEX1 (0.45) ALDH1A1KDM4ECYP3A4POLB
SCHEMBL5115021 0.71 XDH (0.49) ALDH1A1KDM4EHSD17B10CYP3A4CHEK2
SCHEMBL30980977 0.71 POLB (0.43) KDM4ECYP3A4HDAC1POLBKAT2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 ALDH1A1 2454/4885KDM4E 2017/4885HSD17B10 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.